Lee Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Lee Financial’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-245	Closed	-$27.9K	–	986
2022 Q4	$27.9K	Hold	245	–	–	﹤0.01%	301
2022 Q3	$15K	Sell	245 -28	-10%	-$1.96K	﹤0.01%	375
2022 Q2	$22K	Hold	273	–	–	﹤0.01%	326
2022 Q1	$29K	Sell	273 -47	-15%	-$4.58K	0.01%	292
2021 Q4	$34K	Buy	320 +47	+17%	+$5.13K	0.01%	301
2021 Q3	$30K	Hold	273	–	–	0.01%	279
2021 Q2	$26K	Buy	273 +28	+11%	+$2.58K	0.01%	291
2021 Q1	$23K	Buy	245 +45	+23%	+$3.8K	0.01%	291
2020 Q4	$15K	Buy	+200	New	+$14.9K	﹤0.01%	330

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lee Financial's HZNP Position: Q1 2023 in Review

Lee Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 245 shares — an estimated $27.9K sold.

Lee Financial first reported a position in HZNP in Q4 2020 and held it in 9 quarters. The position peaked at $34K in Q4 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Lee Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Lee Financial sold 245 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $27.9K.
Lee Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 9 quarters.
Lee Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $34K in Q4 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Lee Financial's 13F filing for Q1 2023, filed 15 May 2023.